Skip to main content
Porto

PMMNG logo

  • Home
  • Our Meetings
    • Monthly PMMNG Meetings
    • Steering Committee Meetings
  • Myeloma Events
  • Our Members
  • Miles for Myeloma
  • Diversity & Inclusion
  • Resources
    • Myeloma Education Resources
    • Myeloma and Cancer Foundations
    • Regional Myeloma Support Groups
    • Publications and Newsletters
    • Cancer Support Networks
    • Treatments
    • Financial Assistance
    • Caregivers
  • Clinical Trials

Previous Meetings

  • March 2023 PMMNG Meeting: Open Discussion
  • February 2023 PMMNG Meeting - Update from ASH 2022 by Dr. Adam Cohen
  • January 2023 - LLS Current Support Program for Multiple Myeloma
  • December 2022 - PMMNG Year End Celebration
  • November 2022 PMMNG Meeting: Annual Health Insurance Navigation Session
  • October 2022 PMMNG Meeting: Open Discussion
  • September 2022 PMMNG Meeting: Open Discussion
  • No PMMNG Meeting in August
  • July 2022 PMMNG Meeting - Medical Marijuana 101: What to Know, Where to Go, What We Are Learning
  • June 2022 PMMNG Meeting: "Approaching the Conversation: Supporting Patient-Provider Communication in Medical Treatment Decisions"
  • May 2022 PMMNG Meeting: Open Discussion
  • April 2022 PMMNG Meeting: "It's More Than A Will" Presented by Colleen Erb and Christina Bach

February 2017: ASH 2016 Highlights

The February 11, 2017 program will be a presentation of highlights about Multiple Myeloma research and treatment from the recent annual ASH (American of Society of Hematology) meeting. Our speaker will be  Adam D. Cohen, MD, Assistant Professor and Director of Myeloma Immunotherapy at the Abramson Cancer Center of the U of Pennsylvania. He will also provide a general overview of how immunotherapy is being used in treating myeloma. Lunch will be provided by Takeda Pharmaceuticals.

Dr. Cohen's slides

Tags
meeting
pmmng
ash
research
treatment
upenn